BEIJING,Nov. 19,2024-- China\'s continuous improvement of air quality and reduction of greenhouse gas emissions has benefited not only the country itself,but also the rest of Asia and the world,foreig
READ MOREPrioritizing research integrity with enhanced filters to address publication and citation manipulation
TAIPEI,Nov. 19,2024-- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product,TAH3311,an innovative antithrombotic oral dissolvin
GUANGZHOU,China,Nov. 16,2024-- The Sun Yat-sen University (SYSU)held the Celebration Conference for the 100th Anniversary of SYSU and Innovation-Driven Development Forum in the university on the morni
BEIJING,Nov. 16,2024-- "FromChancay to Shanghai" has become a popular slogan in Peru as the Chancay Port,a flagship project of the China-proposed Belt and Road Initiative (BRI),held a grand
SEOUL,South Korea,Nov. 16,2024-- In 2023,d\'Alba achieved a major milestone as Korea\'s top revenue-generating independent skincare brand. This accomplishment,in a market heavily populated,has solidif
HANGZHOU,China,Nov. 14,2024-- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an intelligent learning company with industry-leading technology in China,today announced its unau
BANGKOK,Nov. 14,2024-- The highly anticipated firstChina-ASEAN AI-Empower Cross-Border Digital Marketing Competition was launched at Chulalongkorn University in Bangkok,Thailand on the morning of Nove
KUALA LUMPUR,Malaysia,Nov. 14,2024--The Contact Centre Association of Malaysia (CCAM) today proudly launched CX Malaysia,a chapter dedicated at elevating customer experience (CX) standards in Malaysia
Lillytodrivenext-generationAI-powereddigitalhealthtechnologyresearchinSingapore SINGAPORE,Nov. 14,2024-- Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP),a wholly owned subsidiar
SINGAPORE,Nov. 14,2024-- BB Energy andSGTraDex renew strategic partnership to advance digital borrowing base financing across Asia. This continued collaboration underscores both companies\' commitment
Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study ofuliledlimab in first-line mNSCLC in 1H 2025
CHONGQING,China,Nov. 14,2024-- A news report from iChongqing: On November 12,the 6thChina-ASEAN Legal Cooperation Forum kicked off in Southwest China\'s Chongqing municipality.
© OfficialAffairs
